Robert Valuck - Publications

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Pharmacy, Finance, Health Care Management, Medicine and Surgery

94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Iosifescu DV, Neborsky RJ, Valuck RJ. The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy. Neuropsychiatric Disease and Treatment. 12: 2131-42. PMID 27601908 DOI: 10.2147/NDT.S113712  0.52
2016 Padula WV, Gibbons RD, Pronovost PJ, Hedeker D, Mishra MK, Makic MB, Bridges JF, Wald HL, Valuck RJ, Ginensky AJ, Ursitti A, Venable LR, Epstein Z, Meltzer DO. Using clinical data to predict high-cost performance coding issues associated with pressure ulcers: a multilevel cohort model. Journal of the American Medical Informatics Association : Jamia. PMID 27539199 DOI: 10.1093/jamia/ocw118  0.52
2016 Padula WV, Gibbons RD, Valuck RJ, Makic MB, Mishra MK, Pronovost PJ, Meltzer DO. Are Evidence-based Practices Associated With Effective Prevention of Hospital-acquired Pressure Ulcers in US Academic Medical Centers? Medical Care. 54: 512-8. PMID 27078824 DOI: 10.1097/MLR.0000000000000516  0.52
2016 Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Multiple sclerosis prevalence in the United States commercially insured population. Neurology. PMID 26888980 DOI: 10.1212/WNL.0000000000002469  0.52
2016 Padula WV, Gibbons RD, Valuck RJ, Makic MBF, Mishra MK, Pronovost PJ, Meltzer DO. Are Evidence-based Practices Associated With Effective Prevention of Hospital-acquired Pressure Ulcers in US Academic Medical Centers? Medical Care. DOI: 10.1097/MLR.0000000000000516  0.52
2015 Valuck RJ, Libby AM, Anderson HD, Allen RR, Strombom I, Marangell LB, Perahia D. Comparison of antidepressant classes and the risk and time course of suicide attempts in adults: propensity matched, retrospective cohort study. The British Journal of Psychiatry : the Journal of Mental Science. PMID 26635328 DOI: 10.1192/bjp.bp.114.150839  0.52
2015 Padula WV, Mishra MK, Makic MB, Wald HL, Campbell JD, Nair KV, Valuck RJ. Increased Adoption of Quality Improvement Interventions to Implement Evidence-Based Practices for Pressure Ulcer Prevention in U.S. Academic Medical Centers. Worldviews On Evidence-Based Nursing / Sigma Theta Tau International, Honor Society of Nursing. PMID 26462012 DOI: 10.1111/wvn.12108  0.52
2015 Feinstein JA, Feudtner C, Valuck RJ, Kempe A. The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee-for-service Medicaid patients. Pharmacoepidemiology and Drug Safety. 24: 1049-57. PMID 26248529 DOI: 10.1002/pds.3843  0.52
2015 Padula WV, Makic MB, Wald HL, Campbell JD, Nair KV, Mishra MK, Valuck RJ. Hospital-Acquired Pressure Ulcers at Academic Medical Centers in the United States, 2008-2012: Tracking Changes Since the CMS Nonpayment Policy. Joint Commission Journal On Quality and Patient Safety / Joint Commission Resources. 41: 257-63. PMID 25990891  0.52
2015 Padula WV, Makic MB, Mishra MK, Campbell JD, Nair KV, Wald HL, Valuck RJ. Comparative effectiveness of quality improvement interventions for pressure ulcer prevention in academic medical centers in the United States. Joint Commission Journal On Quality and Patient Safety / Joint Commission Resources. 41: 246-5. PMID 25990890  0.52
2015 Padula WV, Valuck RJ, Makic MB, Wald HL. Factors Influencing Adoption of Hospital-Acquired Pressure Ulcer Prevention Programs in US Academic Medical Centers. Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society / Wocn. 42: 327-30. PMID 25933124 DOI: 10.1097/WON.0000000000000145  0.52
2015 Anderson HD, Pace WD, Brandt E, Nielsen RD, Allen RR, Libby AM, West DR, Valuck RJ. Monitoring suicidal patients in primary care using electronic health records. Journal of the American Board of Family Medicine : Jabfm. 28: 65-71. PMID 25567824 DOI: 10.3122/jabfm.2015.01.140181  0.52
2015 Gibbons RD, Coca Perraillon M, Hur K, Conti RM, Valuck RJ, Brent DA. Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents. Pharmacoepidemiology and Drug Safety. 24: 208-14. PMID 25263479 DOI: 10.1002/pds.3713  0.52
2014 Padula WV, Mishra MK, Makic MB, Valuck RJ. A framework of quality improvement interventions to implement evidence-based practices for pressure ulcer prevention. Advances in Skin & Wound Care. 27: 280-4; quiz 285-6. PMID 24836619 DOI: 10.1097/01.ASW.0000450703.87099.5b  0.52
2014 Cochran BN, Flentje A, Heck NC, Van Den Bos J, Perlman D, Torres J, Valuck R, Carter J. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals. Drug and Alcohol Dependence. 138: 202-8. PMID 24679839 DOI: 10.1016/j.drugalcdep.2014.02.701  0.52
2014 Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier RW. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 189: 1052-64. PMID 24617842 DOI: 10.1164/rccm.201401-0058OC  0.52
2013 Hammermeister K, Bronsert M, Henderson WG, Coombs L, Hosokawa P, Brandt E, Bryan C, Valuck R, West D, Liaw W, Ho M, Pace W. Risk-adjusted comparison of blood pressure and low-density lipoprotein (LDL) noncontrol in primary care offices. Journal of the American Board of Family Medicine : Jabfm. 26: 658-68. PMID 24204062 DOI: 10.3122/jabfm.2013.06.130017  0.52
2013 Bronsert MR, Henderson WG, Valuck R, Hosokawa P, Hammermeister K. Comparative effectiveness of antihypertensive therapeutic classes and treatment strategies in the initiation of therapy in primary care patients: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study. Journal of the American Board of Family Medicine : Jabfm. 26: 529-38. PMID 24004705 DOI: 10.3122/jabfm.2013.05.130048  0.52
2013 Davis LA, Cannon GW, Pointer LF, Haverhals LM, Wolff RK, Mikuls TR, Reimold AM, Kerr GS, Richards JS, Johnson DS, Valuck R, Prochazka A, Caplan L. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis. The Journal of Rheumatology. 40: 809-17. PMID 23547211 DOI: 10.3899/jrheum.121012  0.52
2013 Czaja AS, Valuck RJ, Anderson HD. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events. Pharmacoepidemiology and Drug Safety. 22: 607-14. PMID 23456956 DOI: 10.1002/pds.3420  0.52
2013 Slejko JF, Libby AM, Nair KV, Valuck RJ, Campbell JD. Pharmacoeconomics and outcomes research degree-granting PhD programs in the United States. Research in Social & Administrative Pharmacy : Rsap. 9: 108-13. PMID 22554392 DOI: 10.1016/j.sapharm.2012.03.002  0.52
2013 Valdez C, Namdar R, Valuck R. Impact of pharmacy experience, GPA, age, education, and therapeutic review on knowledge retention and clinical confidence Currents in Pharmacy Teaching and Learning. 5: 358-364. DOI: 10.1016/j.cptl.2013.06.010  0.52
2012 Padula WV, Makic MB, Mishra MK, Wald H, Nair KV, Campbell J, Valuck R. PHS97 An Off-the-Shelf Catalogue of Quality Improvement Interventions to Implement in the Prevention of Pressure Ulcers for Hospital Settings. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: A535. PMID 27205219 DOI: 10.1016/j.jval.2012.08.1870  0.52
2012 Valuck RJ, Anderson HO, Libby AM, Brandt E, Bryan C, Allen RR, Staton EW, West DR, Pace WD. Enhancing electronic health record measurement of depression severity and suicide ideation: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study. Journal of the American Board of Family Medicine : Jabfm. 25: 582-93. PMID 22956694 DOI: 10.3122/jabfm.2012.05.110053  0.52
2012 Hoffman DA, Debattista C, Valuck RJ, Iosifescu DV. Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review. Neuropsychiatric Disease and Treatment. 8: 277-84. PMID 22802691 DOI: 10.2147/NDT.S31665  0.52
2012 Czaja AS, Valuck R. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence. Pharmacoepidemiology and Drug Safety. 21: 997-1004. PMID 22760843 DOI: 10.1002/pds.3312  0.52
2012 Schumock GT, Stayner LT, Valuck RJ, Joo MJ, Gibbons RD, Lee TA. Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study. The Journal of Allergy and Clinical Immunology. 130: 368-75. PMID 22698520 DOI: 10.1016/j.jaci.2012.04.035  0.52
2012 Reiter PD, Wathen B, Valuck RJ, Dobyns EL. Thrombosis risk factor assessment and implications for prevention in critically ill children. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 13: 381-6. PMID 22198812 DOI: 10.1097/PCC.0b013e31823893f5  0.52
2012 Anderson HD, Pace WD, Libby AM, West DR, Valuck RJ. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Clinical Therapeutics. 34: 113-23. PMID 22177545 DOI: 10.1016/j.clinthera.2011.11.024  0.52
2012 Schumock GT, Gibbons RD, Lee TA, Joo MJ, Stayner LT, Valuck RJ. The Association Between Leukotriene-Modifying Agents and Spontaneously Reported Suicide Drug Information Journal. 46: 99-106. DOI: 10.1177/0092861511427856  0.52
2011 Schumock GT, Gibbons RD, Lee TA, Joo MJ, Valuck RJ, Stayner LT. Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US. Drug, Healthcare and Patient Safety. 3: 47-52. PMID 22046105 DOI: 10.2147/DHPS.S23665  0.52
2011 Sanglier T, Saragoussi D, Milea D, Auray JP, Valuck RJ, Tournier M. Comparing antidepressant treatment patterns in older and younger adults: a claims database analysis. Journal of the American Geriatrics Society. 59: 1197-205. PMID 21718261 DOI: 10.1111/j.1532-5415.2011.03457.x  0.52
2011 Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD. Association between leukotriene-modifying agents and suicide: what is the evidence? Drug Safety. 34: 533-44. PMID 21663330 DOI: 10.2165/11587260-000000000-00000  0.52
2011 Henderson KC, Hindman J, Johnson SC, Valuck RJ, Kiser JJ. Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV. Aids Patient Care and Stds. 25: 221-8. PMID 21323566 DOI: 10.1089/apc.2010.0324  0.52
2011 Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, Campagna E, Newcomer JW. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiology and Drug Safety. 20: 66-75. PMID 21182154 DOI: 10.1002/pds.2062  0.52
2010 Reiter PD, Huff AD, Knupp KG, Valuck RJ. Intravenous levetiracetam in the management of acute seizures in children. Pediatric Neurology. 43: 117-21. PMID 20610122 DOI: 10.1016/j.pediatrneurol.2010.03.017  0.52
2010 Libby AM, Pace W, Bryan C, Anderson HO, Ellis SL, Allen RR, Brandt E, Huebschmann AG, West D, Valuck RJ. Comparative effectiveness research in DARTNet primary care practices: point of care data collection on hypoglycemia and over-the-counter and herbal use among patients diagnosed with diabetes. Medical Care. 48: S39-44. PMID 20473193 DOI: 10.1097/MLR.0b013e3181ddc7b0  0.52
2010 Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, Campagna E, Newcomer JW. Metabolic screening in children receiving antipsychotic drug treatment. Archives of Pediatrics & Adolescent Medicine. 164: 344-51. PMID 20368487 DOI: 10.1001/archpediatrics.2010.48  0.52
2010 Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Archives of General Psychiatry. 67: 17-24. PMID 20048219 DOI: 10.1001/archgenpsychiatry.2009.179  0.52
2009 Valuck RJ, Orton HD, Libby AM. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. The Journal of Clinical Psychiatry. 70: 1069-77. PMID 19758520 DOI: 10.4088/JCP.08m04943  0.52
2009 Pace WD, Cifuentes M, Valuck RJ, Staton EW, Brandt EC, West DR. An electronic practice-based network for observational comparative effectiveness research. Annals of Internal Medicine. 151: 338-40. PMID 19638402  0.52
2009 Libby AM, Orton HD, Valuck RJ. Persisting decline in depression treatment after FDA warnings. Archives of General Psychiatry. 66: 633-9. PMID 19487628 DOI: 10.1001/archgenpsychiatry.2009.46  0.52
2009 Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure. Clinical Therapeutics. 31: 632-43. PMID 19393854 DOI: 10.1016/j.clinthera.2009.03.019  0.52
2009 Williams-Skipp C, Raman T, Valuck RJ, Watkins H, Palmer BE, Scheinman RI. Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model. Arthritis and Rheumatism. 60: 408-18. PMID 19180511 DOI: 10.1002/art.24260  0.52
2008 Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data. The Journal of Clinical Psychiatry. 69: 316-22. PMID 18251625  0.52
2008 Morrato EH, Libby AM, Orton HD, Degruy FV, Brent DA, Allen R, Valuck RJ. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. The American Journal of Psychiatry. 165: 42-50. PMID 17986680 DOI: 10.1176/appi.ajp.2008.165.7.A42  0.52
2007 Valuck RJ, Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R. How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs. Current Medical Research and Opinion. 23: 2567-76. PMID 17848204 DOI: 10.1185/030079907X233214  0.52
2007 Baldessarini RJ, Tondo L, Strombom IM, Dominguez S, Fawcett J, Licinio J, Oquendo MA, Tollefson GD, Valuck RJ, Tohen M. Ecological studies of antidepressant treatment and suicidal risks. Harvard Review of Psychiatry. 15: 133-45. PMID 17687708 DOI: 10.1080/10673220701551102  0.52
2007 Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. The American Journal of Psychiatry. 164: 1198-205. PMID 17671282 DOI: 10.1176/appi.ajp.2007.07010007  0.52
2007 Reiter PD, Valuck RJ, Taylor RS. Evaluation of off-label recombinant activated factor VII for multiple indications in children. Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 13: 233-40. PMID 17636185 DOI: 10.1177/1076029607302402  0.52
2007 McClure DL, Valuck RJ, Glanz M, Murphy JR, Hokanson JE. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. Journal of Clinical Epidemiology. 60: 812-8. PMID 17606177 DOI: 10.1016/j.jclinepi.2006.11.006  0.52
2007 Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. The American Journal of Psychiatry. 164: 884-91. PMID 17541047 DOI: 10.1176/ajp.2007.164.6.884  0.52
2007 Glassman PA, Belperio P, Lanto A, Simon B, Valuck R, Sayers J, Lee M. The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population. Journal of the American Medical Informatics Association : Jamia. 14: 424-31. PMID 17460134 DOI: 10.1197/jamia.M2313  0.52
2007 Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Clinical Therapeutics. 29: 183-95. PMID 17379060 DOI: 10.1016/j.clinthera.2007.01.002  0.52
2007 McClure DL, Valuck RJ, Glanz M, Hokanson JE. Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present. Pharmacoepidemiology and Drug Safety. 16: 132-43. PMID 17072896 DOI: 10.1002/pds.1341  0.52
2007 Valuck RJ, Libby AM, Benton TD, Evans DL. A descriptive analysis of 10,000 suicide attempters in United States managed care plans, 1998-2005 Primary Psychiatry. 14: 52-60.  0.52
2006 Reiter PD, Novak K, Valuck RJ, Rosenberg AA, Fish D. Effect of a closed drug-delivery system on the incidence of nosocomial and catheter-related bloodstream infections in infants. Epidemiology and Infection. 134: 285-91. PMID 16490132 DOI: 10.1017/S0950268805004851  0.52
2005 Reiter PD, Rosenberg AA, Valuck R, Novak K. Effect of short-term erythropoietin therapy in anemic premature infants. Journal of Perinatology : Official Journal of the California Perinatal Association. 25: 125-9. PMID 15526012 DOI: 10.1038/sj.jp.7211220  0.52
2005 Saseen JJ, Williams SA, Valuck RJ, O'Donnell JC, McDonough K. The performance gap between clinical trials and patient treatment for dyslipidemia: A comprehensive review Disease Management and Health Outcomes. 13: 255-265. DOI: 10.2165/00115677-200513040-00004  0.52
2005 Sullivan PW, Valuck R, Brixner DI, Armstrong EP. Managed care's response to a pharmacoeconomic model of serotonin reuptake inhibitors P and T. 30: 178-181.  0.52
2005 Nair KV, Valuck RJ, Allen RR, Lewis SJ. Impact of increased copayments on the discontinuation/switching rates of nonformulary medications Journal of Pharmacy Technology. 21: 137-143.  0.52
2005 Sullivan PW, Valuck R, Brixner DI, Armstrong EP. A pharmacoeconomic model for making value-based decisions about serotonin reuptake inhibitors P and T. 30.  0.52
2004 Nair KV, Valuck RJ. Consumer responses to a pharmacy benefit report card. Journal of Health Care Finance. 31: 55-72. PMID 15816229  0.52
2004 Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. Cns Drugs. 18: 1119-32. PMID 15581382 DOI: 10.2165/00023210-200418150-00006  0.52
2004 Sullivan PW, Valuck R, Saseen J, MacFall HM. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. Cns Drugs. 18: 911-32. PMID 15521793 DOI: 10.2165/00023210-200418130-00006  0.52
2004 Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. Journal of Clinical Epidemiology. 57: 422-8. PMID 15135846 DOI: 10.1016/j.jclinepi.2003.08.015  0.52
2004 Valuck R. Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s). The American Journal of Managed Care. 10: 285; author reply 28. PMID 15124506  0.52
2004 Ganther-Urmie JM, Nair KV, Valuck R, McCollum M, Lewis SJ, Turpin RS. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans. The American Journal of Managed Care. 10: 201-8. PMID 15032257  0.52
2004 Nair KV, Valuck RJ. Impact of three-tier pharmacy benefit structures on consumer attitudes, pharmacy, medical utilization and costs: A critical review Disease Management and Health Outcomes. 12: 81-92. DOI: 10.2165/00115677-200412020-00002  0.52
2004 Valuck R. Selective serotonin reuptake inhibitors: A class review P and T. 29: 234-243.  0.52
2003 Valuck RJ, Williams SA, MacArthur M, Saseen JJ, Nair KV, McCollum M, Ensor JE. A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization. Clinical Therapeutics. 25: 2936-57. PMID 14693317 DOI: 10.1016/S0149-2918(03)80346-6  0.52
2003 Nair KV, Wolfe P, Valuck RJ, McCollum MM, Ganther JM, Lewis SJ. Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease. Journal of Managed Care Pharmacy : Jmcp. 9: 123-33. PMID 14613341 DOI: 10.18553/jmcp.2003.9.2.123  0.52
2003 Reiter PD, Sims C, Harmes L, Paisley J, Rosenberg AA, Valuck RJ. Calfactant sterility in multiple doses from single-use vials. The Annals of Pharmacotherapy. 37: 1219-23. PMID 12921502 DOI: 10.1345/aph.1C463  0.52
2002 Roose SP, Katz IR, Pollock BG, Valuck RJ. Contemporary issues in the diagnosis and treatment of late-life depression. Journal of the American Medical Directors Association. 3: H26-9. PMID 12807631 DOI: 10.1016/S1525-8610(04)70513-7  0.52
2002 Ruscin JM, Page RL, Valuck RJ. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor. The Annals of Pharmacotherapy. 36: 812-6. PMID 11978157  0.52
2002 Valuck RJ. Treatment of depression with citalopram, fluoxetine, paroxetine, sertraline, and venlafaxine in managed care: Part 2 - Patient comorbidities and coprescribed therapies Drug Benefit Trends. 14: 33-40.  0.52
2002 Valuck RJ. Treatment of depression with citalopram, fluoxetine, paroxetine, sertraline, and venlafaxine in managed care: Part 1 - Drug selection, dosing, and utilization Drug Benefit Trends. 14: 23-30.  0.52
2002 Nair KV, Ganther JM, Valuck RJ, McCollum M, Lewis SJ. Improving formulary compliance with managed care members Drug Benefit Trends. 14: 44-46.  0.52
2001 Valuck RJ, Perlman JI, Anderson C, Wortman GI. Co-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers: Estimates from three US Veterans Affairs Medical Centers Pharmacoepidemiology and Drug Safety. 10: 511-516. PMID 11828833 DOI: 10.1002/pds.634  0.52
2001 Vander Zanden JA, Valuck RJ, Bunch CL, Perlman JI, Anderson C, Wortman GI. Systemic adverse effects of ophthalmic beta-blockers. The Annals of Pharmacotherapy. 35: 1633-7. PMID 11793633 DOI: 10.1345/aph.18464  0.52
2001 Sherman DS, Clarke SH, Lefkowitz JB, Valuck RJ, Lindenfeld J, Stringer KA. An institution-specific heparin titration nomogram: development, validation, and assessment of compliance. Pharmacotherapy. 21: 1167-74. PMID 11601661  0.52
2001 Carter BL, Malone DC, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, Ellis S, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Dombrowski R, Geraets DR, Amato M. Interpreting the findings of the IMPROVE study American Journal of Health-System Pharmacy. 58: 1330-1337. PMID 11471481  0.52
2001 Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, Okano GJ, Ellis S, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, et al. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Medical Care. 39: 113-122. PMID 11176549  0.52
2000 Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ, Barnette DJ, Sintek CD, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Dombrowski R, Geraets DR, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 20: 1508-16. PMID 11130223 DOI: 10.1592/phco.20.19.1508.34852  0.52
2000 Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, Okano GJ, Ellis S, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: The IMPROVE study Pharmacotherapy. 20: 1149-1158. PMID 11034037 DOI: 10.1592/phco.20.15.1149.34590  0.52
2000 Reiter PD, Rosenberg AA, Valuck RJ. Factors associated with successful epoetin alfa therapy in premature infants. The Annals of Pharmacotherapy. 34: 433-9. PMID 10772426  0.52
2000 Billups SJ, Okano G, Malone D, Carter BL, Valuck R, Barnette DJ, Sintek CD. Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers American Journal of Health-System Pharmacy. 57: 29-39. PMID 10630554 DOI: 10.1093/ajhp/57.1.29  0.52
2000 Valuck RJ, Byrns PJ, Fulda TR, Zanden JV, Parker S. Methodology for assessing drug-drug interaction evidence in the peer-reviewed medical literature Current Therapeutic Research - Clinical and Experimental. 61: 553-568. DOI: 10.1016/S0011-393X(00)80038-7  0.52
2000 Fulda TR, Valuck RJ, Zanden JV, Parker S, Byrns PJ. Disagreement among drug compendia on inclusion and ratings of drug-drug interactions Current Therapeutic Research - Clinical and Experimental. 61: 540-548. DOI: 10.1016/S0011-393X(00)80036-3  0.52
2000 Carter BL, Brunson BJ, Hatfield CL, Valuck RJ. Description of an introductory course designed to socialize pharmacy students American Journal of Pharmaceutical Education. 64: 166-173.  0.52
1999 Malone DC, Billups SJ, Valuck RJ, Carter BL. Development of a chronic disease indicator score using a veterans affairs medical center medication database Journal of Clinical Epidemiology. 52: 551-557. PMID 10408995 DOI: 10.1016/S0895-4356(99)00029-3  0.52
1998 Carter BL, Malone DC, Valuck RJ, Barnette DJ, Sintek CD, Billups SJ. The IMPROVE study: Background and study design American Journal of Health-System Pharmacy. 55: 62-67. PMID 9437477  0.52
1997 Lambert BL, Salmon JW, Stubbings J, Gilomen-Study G, Valuck RJ, Kezlarian K. Factors associated with antibiotic prescribing in a managed care setting: an exploratory investigation. Social Science & Medicine (1982). 45: 1767-79. PMID 9447627 DOI: 10.1016/S0277-9536(97)00108-1  0.52
1995 Moore LL, Valuck R, McDougall C, Fink W. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives Contraception. 52: 215-219. PMID 8605778 DOI: 10.1016/0010-7824(95)00189-H  0.52
Show low-probability matches.